Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta
- PMID: 18209032
- DOI: 10.4049/jimmunol.180.3.1382
Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta
Abstract
Osteoclasts are bone-resorbing cells that are differentiated from hemopoietic precursors of the monocyte-macrophage lineage. Stimulation of TLRs has been shown to positively or negatively modulate osteoclast differentiation, depending on the experimental condition. However, the molecular mechanism by which this modulation takes place remains unclear. In the present study, we examined the effects of flagellin, a specific microbial ligand of TLR5, on the receptor activator of NF-kappaB ligand (RANKL)-stimulated osteoclastogenesis. Flagellin suppressed RANKL induction of c-Fos protein expression in bone marrow-derived macrophages without affecting c-Fos mRNA expression. Ectopic overexpression of c-Fos and a constitutively active form of NFATc1 reversed the flagellin-induced anti-osteoclastogenic effect. The inhibitory effect of flagellin was mediated by IFN-beta production. Flagellin stimulated IFN-beta expression and release in bone marrow-derived macrophages, and IFN-beta-neutralizing Ab prevented the flagellin-induced c-Fos down-regulation and the anti-osteoclastogenic effect. IFN-beta gene induction by flagellin, LPS, or RANKL was dependent on STAT1 activation. Treatment with flagellin or RANKL stimulated STAT1 activation, and STAT1 deficiency or the JAK2 inhibitor AG490 dramatically prevented IFN-beta induction in response to flagellin or RANKL. In addition, STAT1 deficiency abolished the anti-osteoclastogenic effect induced by flagellin or LPS. In contrast, flagellin stimulated osteoclast differentiation in cocultures of osteoblasts and bone marrow cells without inducing IFN-beta. Thus, IFN-beta acts as a critical modulator of osteoclastogenesis in response to TLR5 activation.
Similar articles
-
Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).Immunol Lett. 2012 Feb 29;142(1-2):34-40. doi: 10.1016/j.imlet.2011.12.001. Epub 2011 Dec 13. Immunol Lett. 2012. PMID: 22193059
-
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6. Biochem Pharmacol. 2013. PMID: 23928189
-
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.Mol Pharmacol. 2010 Jan;77(1):17-25. doi: 10.1124/mol.109.057877. Epub 2009 Oct 14. Mol Pharmacol. 2010. PMID: 19828731
-
Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation.Front Immunol. 2019 Jul 17;10:1663. doi: 10.3389/fimmu.2019.01663. eCollection 2019. Front Immunol. 2019. PMID: 31379855 Free PMC article. Review.
-
Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology.Keio J Med. 2004 Jun;53(2):78-84. doi: 10.2302/kjm.53.78. Keio J Med. 2004. PMID: 15247511 Review.
Cited by
-
TRAP-positive osteoclast precursors mediate ROS/NO-dependent bactericidal activity via TLR4.Free Radic Biol Med. 2016 Aug;97:330-341. doi: 10.1016/j.freeradbiomed.2016.06.021. Epub 2016 Jun 22. Free Radic Biol Med. 2016. PMID: 27343691 Free PMC article.
-
Roles of Toll-like Receptor Signaling in Inflammatory Bone Resorption.Biology (Basel). 2024 Sep 4;13(9):692. doi: 10.3390/biology13090692. Biology (Basel). 2024. PMID: 39336119 Free PMC article. Review.
-
Signaling pathway STAT1 is strongly activated by IFN-β in the pathogenesis of osteoporosis.Eur J Med Res. 2015 Jan 7;20(1):1. doi: 10.1186/s40001-014-0074-4. Eur J Med Res. 2015. PMID: 25563300 Free PMC article.
-
Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages.Sci Rep. 2016 Oct 13;6:34752. doi: 10.1038/srep34752. Sci Rep. 2016. PMID: 27734899 Free PMC article.
-
SREBP2 restricts osteoclast differentiation and activity by regulating IRF7 and limits inflammatory bone erosion.Bone Res. 2024 Aug 27;12(1):48. doi: 10.1038/s41413-024-00354-4. Bone Res. 2024. PMID: 39191742 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous